Viewing Study NCT05580861


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-01-29 @ 7:50 PM
Study NCT ID: NCT05580861
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2022-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Sponsor:
Organization: